Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort

Nicola A. Hanania, Hana Müllerova, Nicholas W. Locantore, Jørgen Vestbo, Michael L. Watkins, Emiel F.M. Wouters, Stephen Israel Rennard, Amir Sharafkhaneh

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Rationale: Depression is prevalent in patients with chronic obstructive pulmonary disease (COPD); however, its etiology and relationship to the clinical features of COPD are not well understood. Objectives: Using data from a large cohort, we explored prevalence and determinants of depression in subjects with COPD. Methods: The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study is an observational 3-year multicenter study that enrolled smokers with and without COPD and nonsmoker controls. At baseline, several patient-reported outcomes were measured including the Center for Epidemiologic Studies of Depression Scale. For the purposes of this analysis, depression was defined as a score of 16 and higher on this scale, which reflects a high load of depressive symptoms and has a good correspondence with a clinical diagnosis of major depression. Measurements and Main Results: The study cohort consisted of 2,118 subjects with COPD; 335 smokers without COPD (smokers); and 243 nonsmokers without COPD (nonsmokers). A total of 26%, 12%, and7% of COPD, smokers, and nonsmokers, respectively, suffered from depression. In subjects with COPD, higher depression prevalence was seen in females, current smokers, and those with severe disease (Global Initiative for Obstructive Lung Disease [GOLD]-defined). Multivariate modeling of depression determinants in subjects with COPD revealed that increased fatigue, higher St. George's Respiratory Questionnaire for COPD patients score, younger age, female sex, history of cardiovascular disease, and current smoking status were all significantly associated with depression; physiologic and biologic measures were weak or nonsignificant descriptors. Conclusions: Depression is more prevalent in subjects with COPD compared with smokers and nonsmokers without COPD. Clinical and biologic measures were less important determinants of depression in COPD than disease symptoms and quality-of-life. Clinical trial registered with www.clinicaltrials.gov (NCT 00292552).

Original languageEnglish (US)
Pages (from-to)604-611
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume183
Issue number5
DOIs
StatePublished - Mar 1 2011

Fingerprint

Chronic Obstructive Pulmonary Disease
Depression
Obstructive Lung Diseases
Multicenter Studies
Observational Studies
Fatigue
Epidemiologic Studies
Cohort Studies
Cardiovascular Diseases
Biomarkers
Smoking
Quality of Life
Clinical Trials

Keywords

  • Chronic obstructive pulmonary disease
  • Comorbidities
  • Depression

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Hanania, N. A., Müllerova, H., Locantore, N. W., Vestbo, J., Watkins, M. L., Wouters, E. F. M., ... Sharafkhaneh, A. (2011). Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. American Journal of Respiratory and Critical Care Medicine, 183(5), 604-611. https://doi.org/10.1164/rccm.201003-0472OC

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. / Hanania, Nicola A.; Müllerova, Hana; Locantore, Nicholas W.; Vestbo, Jørgen; Watkins, Michael L.; Wouters, Emiel F.M.; Rennard, Stephen Israel; Sharafkhaneh, Amir.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 183, No. 5, 01.03.2011, p. 604-611.

Research output: Contribution to journalArticle

Hanania, NA, Müllerova, H, Locantore, NW, Vestbo, J, Watkins, ML, Wouters, EFM, Rennard, SI & Sharafkhaneh, A 2011, 'Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort', American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 5, pp. 604-611. https://doi.org/10.1164/rccm.201003-0472OC
Hanania, Nicola A. ; Müllerova, Hana ; Locantore, Nicholas W. ; Vestbo, Jørgen ; Watkins, Michael L. ; Wouters, Emiel F.M. ; Rennard, Stephen Israel ; Sharafkhaneh, Amir. / Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. In: American Journal of Respiratory and Critical Care Medicine. 2011 ; Vol. 183, No. 5. pp. 604-611.
@article{92886fb33da24e54aedf3021815f13a9,
title = "Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort",
abstract = "Rationale: Depression is prevalent in patients with chronic obstructive pulmonary disease (COPD); however, its etiology and relationship to the clinical features of COPD are not well understood. Objectives: Using data from a large cohort, we explored prevalence and determinants of depression in subjects with COPD. Methods: The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study is an observational 3-year multicenter study that enrolled smokers with and without COPD and nonsmoker controls. At baseline, several patient-reported outcomes were measured including the Center for Epidemiologic Studies of Depression Scale. For the purposes of this analysis, depression was defined as a score of 16 and higher on this scale, which reflects a high load of depressive symptoms and has a good correspondence with a clinical diagnosis of major depression. Measurements and Main Results: The study cohort consisted of 2,118 subjects with COPD; 335 smokers without COPD (smokers); and 243 nonsmokers without COPD (nonsmokers). A total of 26{\%}, 12{\%}, and7{\%} of COPD, smokers, and nonsmokers, respectively, suffered from depression. In subjects with COPD, higher depression prevalence was seen in females, current smokers, and those with severe disease (Global Initiative for Obstructive Lung Disease [GOLD]-defined). Multivariate modeling of depression determinants in subjects with COPD revealed that increased fatigue, higher St. George's Respiratory Questionnaire for COPD patients score, younger age, female sex, history of cardiovascular disease, and current smoking status were all significantly associated with depression; physiologic and biologic measures were weak or nonsignificant descriptors. Conclusions: Depression is more prevalent in subjects with COPD compared with smokers and nonsmokers without COPD. Clinical and biologic measures were less important determinants of depression in COPD than disease symptoms and quality-of-life. Clinical trial registered with www.clinicaltrials.gov (NCT 00292552).",
keywords = "Chronic obstructive pulmonary disease, Comorbidities, Depression",
author = "Hanania, {Nicola A.} and Hana M{\"u}llerova and Locantore, {Nicholas W.} and J{\o}rgen Vestbo and Watkins, {Michael L.} and Wouters, {Emiel F.M.} and Rennard, {Stephen Israel} and Amir Sharafkhaneh",
year = "2011",
month = "3",
day = "1",
doi = "10.1164/rccm.201003-0472OC",
language = "English (US)",
volume = "183",
pages = "604--611",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort

AU - Hanania, Nicola A.

AU - Müllerova, Hana

AU - Locantore, Nicholas W.

AU - Vestbo, Jørgen

AU - Watkins, Michael L.

AU - Wouters, Emiel F.M.

AU - Rennard, Stephen Israel

AU - Sharafkhaneh, Amir

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Rationale: Depression is prevalent in patients with chronic obstructive pulmonary disease (COPD); however, its etiology and relationship to the clinical features of COPD are not well understood. Objectives: Using data from a large cohort, we explored prevalence and determinants of depression in subjects with COPD. Methods: The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study is an observational 3-year multicenter study that enrolled smokers with and without COPD and nonsmoker controls. At baseline, several patient-reported outcomes were measured including the Center for Epidemiologic Studies of Depression Scale. For the purposes of this analysis, depression was defined as a score of 16 and higher on this scale, which reflects a high load of depressive symptoms and has a good correspondence with a clinical diagnosis of major depression. Measurements and Main Results: The study cohort consisted of 2,118 subjects with COPD; 335 smokers without COPD (smokers); and 243 nonsmokers without COPD (nonsmokers). A total of 26%, 12%, and7% of COPD, smokers, and nonsmokers, respectively, suffered from depression. In subjects with COPD, higher depression prevalence was seen in females, current smokers, and those with severe disease (Global Initiative for Obstructive Lung Disease [GOLD]-defined). Multivariate modeling of depression determinants in subjects with COPD revealed that increased fatigue, higher St. George's Respiratory Questionnaire for COPD patients score, younger age, female sex, history of cardiovascular disease, and current smoking status were all significantly associated with depression; physiologic and biologic measures were weak or nonsignificant descriptors. Conclusions: Depression is more prevalent in subjects with COPD compared with smokers and nonsmokers without COPD. Clinical and biologic measures were less important determinants of depression in COPD than disease symptoms and quality-of-life. Clinical trial registered with www.clinicaltrials.gov (NCT 00292552).

AB - Rationale: Depression is prevalent in patients with chronic obstructive pulmonary disease (COPD); however, its etiology and relationship to the clinical features of COPD are not well understood. Objectives: Using data from a large cohort, we explored prevalence and determinants of depression in subjects with COPD. Methods: The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study is an observational 3-year multicenter study that enrolled smokers with and without COPD and nonsmoker controls. At baseline, several patient-reported outcomes were measured including the Center for Epidemiologic Studies of Depression Scale. For the purposes of this analysis, depression was defined as a score of 16 and higher on this scale, which reflects a high load of depressive symptoms and has a good correspondence with a clinical diagnosis of major depression. Measurements and Main Results: The study cohort consisted of 2,118 subjects with COPD; 335 smokers without COPD (smokers); and 243 nonsmokers without COPD (nonsmokers). A total of 26%, 12%, and7% of COPD, smokers, and nonsmokers, respectively, suffered from depression. In subjects with COPD, higher depression prevalence was seen in females, current smokers, and those with severe disease (Global Initiative for Obstructive Lung Disease [GOLD]-defined). Multivariate modeling of depression determinants in subjects with COPD revealed that increased fatigue, higher St. George's Respiratory Questionnaire for COPD patients score, younger age, female sex, history of cardiovascular disease, and current smoking status were all significantly associated with depression; physiologic and biologic measures were weak or nonsignificant descriptors. Conclusions: Depression is more prevalent in subjects with COPD compared with smokers and nonsmokers without COPD. Clinical and biologic measures were less important determinants of depression in COPD than disease symptoms and quality-of-life. Clinical trial registered with www.clinicaltrials.gov (NCT 00292552).

KW - Chronic obstructive pulmonary disease

KW - Comorbidities

KW - Depression

UR - http://www.scopus.com/inward/record.url?scp=79952220945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952220945&partnerID=8YFLogxK

U2 - 10.1164/rccm.201003-0472OC

DO - 10.1164/rccm.201003-0472OC

M3 - Article

VL - 183

SP - 604

EP - 611

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 5

ER -